MPG.eBooks - Search Results

141

Imiquimod for the treatment of actinic keratosis : a review of clinical effectiveness and cost-effectiveness

by Banerjee, Srabani, Kaunelis, David
Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Cost-Benefit Analysis...”

Read Now

142

Rigid dressings for edema management for leg amputation : a review of clinical and cost-effectiveness

by Banerjee, Srabani, Adcock, Lorna
Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Cost-Benefit Analysis...”

Read Now

143

Custom-made foot orthoses versus prefabricated foot orthoses : a review of clinical effectiveness and cost-effectiveness

by Tran, Khai, Spry, Carolyn
Published 2019

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Cost-Benefit Analysis...”

Read Now

144

Diagnostics Assessment Programme manual

Published 2011

National Institute for Health and Clinical Excellence (NICE)

Subjects: “...Cost-Benefit Analysis...”

Read Now

145

Financial considerations of hospital-based palliative care

by Sullender, Renee T., Selenich, Sarah A.
Published 2016

RTI Press

Subjects: “...Cost-Benefit Analysis / economics...”

Read Now

146

Pharmacoeconomic review report: Ivabradine hydrochloride (Lancora)

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Cost-Benefit Analysis...”

Read Now

147

Pharmacoeconomic review report: Tocilizumab (Actemra) (Hoffman-La Roche Limited)

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Cost-Benefit Analysis...”

Read Now

148

Fetal scalp lactate testing during intrapartum pregnancy with abnormal fetal heart rate : a review of clinical effectiveness, cost-effectiveness, and guidelines

by Young, Calvin, Ryce, Andrea
Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Cost-Benefit Analysis...”

Read Now

149

Pharmacoeconomic review report: Cysteamine delayed-release capsules (Procysbi), Horizon Pharma Ireland Ltd

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Cost-Benefit Analysis...”

Read Now

150

Pharmacoeconomic review report: AbobotulinumtoxinA (Dysport therapeutic) (Ipsen Biopharmaceuticals Canada, Inc.)

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Cost-Benefit Analysis...”

Read Now

151

Multidisciplinary treatment programs for patients with chronic non-malignant pain : a review of clinical effectiveness, cost-effectiveness, and guidelines : an update

by Gauthier, Kasandra, Dulong, Camille, Argáez, Charlene
Published 2019

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Cost-Benefit Analysis...”

Read Now

152

Urinary catheters as replacement feeding tubes : a review of clinical effectiveness, cost-effectiveness, and guidelines

by Gray, Casey, Grobelna, Aleksandra
Published 2019

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Cost-Benefit Analysis...”

Read Now

153

Homelike models in long term care : a review of clinical effectiveness, cost-effectiveness, and guidelines

by Gray, Casey, Farrah, Kelly
Published 2019

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Cost-Benefit Analysis...”

Read Now

154

Disinfection of multi-use ocular equipment for ophthalmological procedures : a review of clinical effectiveness, cost-effectiveness, and guidelines

by Yeung, Shirley S. T., Wright, Mary-Doug
Published 2019

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Cost-Benefit Analysis...”

Read Now

155

Video-oculography for the diagnosis of ocular myasthenia gravis : a review of diagnostic accuracy, cost-effectiveness, and guidelines

by Chao, Yi-Sheng, Argáez, Charlene
Published 2019

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Cost-Benefit Analysis...”

Read Now

156

Pharmacoeconomic review report: Adalimumab (Humira)

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Cost-Benefit Analysis...”

Read Now

157

Optimal strategies for the diagnosis of acute pulmonary embolism: A health technology assessment

by Sinclair, Alison
Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Cost-Benefit Analysis...”

Read Now

158

Pharmacoeconomic review report: Obeticholic acid (Ocaliva) : (Intercept Pharma Canada, Inc.) : indication : for the treatment of primary biliary cholangitis

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Cost-Benefit Analysis...”

Read Now

159

Gastric pH testing for neonatal gastric feeding tube placement : a review of clinical effectiveness, cost-effectiveness and guidelines

by Gray, Casey, Campbell, Kaitryn
Published 2018

CADTH

Subjects: “...Cost-Benefit Analysis...”

Read Now

160

Long term institutional or residential treatment of patients with substance abuse compared to short-term outpatient treatment

by Steiro, Asbjørn, Dalsbø, Therese Kristine, Smedslund, Geir, Hammerstrøm, Karianne Thune
Published 2009

Norwegia Knowledge Centre for the Health Services

Subjects: “...Cost-Benefit Analysis...”

Narrow Search